-
-
Kathy Vuksanaj wrote a new post, Recurrent Mutations in SARS-CoV-2 Doesn't Increase Transmissibility 1 month, 3 weeks ago
Researchers at University College London carried out a large study that suggests that none of the recorded mutations in SARS-CoV-2 increase its transmissibility, contrary to claims from other […]
-
Kathy Vuksanaj wrote a new post, Automated De Novo Monoclonal Antibody Sequencing for Modern Biotech 2 months, 3 weeks ago
Dan Bach Kristensen, PhDPrincipal ScientistSymphogen
Krisztina Radi, PhDPharma & Biopharma Vertical Marketing ManagerChromatography & Mass SpectrometryThermo Fisher Scientific
Ilker Sen, […]
-
Kathy Vuksanaj wrote a new post, Novel Tech Approaches for Analyzing Aggregation 4 months ago
A bunched-up bundle of a protein-based biologic is practically useless. Unfortunately, protein aggregation creates a common problem in the bioprocessing of many therapeutics. Addressing this issue will probably […]
-
Kathy Vuksanaj commented on the post, Newly-Described Mutation Leaves Ashkenazi Jews at Higher Multiple Cancer Risk 5 months, 2 weeks ago
Hi Julie,
GEN is a publishing company. Please contact those involved with the study for any questions you may have. The link to the paper is provided in the article.
-
Kathy Vuksanaj commented on the post, Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development 5 months, 3 weeks ago
The updated version can be found at https://www.genengnews.com/covid-19-candidates/covid-19-drug-and-vaccine-tracker/
-
Kathy Vuksanaj wrote a new post, In-Depth GPCR Signaling Characterization for Improved Drug Discovery 5 months, 3 weeks ago
G protein–coupled receptors (GPCRs) play crucial roles in the regulation of a wide variety of physiological processes and represent one-third of targets with clinically prescribed drugs. Yet, it remains the case t […]
-
Kathy Vuksanaj wrote a new post, Engineering the Immune Response for Therapeutic Success 7 months ago
In the first of the articles included in this eBook, Carl June describes the development of CAR T cells as “a long and winding road.” This and other selected articles indicate why this is so: the immune system is […]
-
Kathy Vuksanaj wrote a new post, 3D Microscopy Keeps Getting Faster, Smarter, Leaner 7 months, 3 weeks ago
With each passing day, continuous advancements are being made in the studies that cutting-edge instruments can perform and in the complexity of the biological samples that are being examined. The number of […]
-
Kathy Vuksanaj wrote a new post, A Winning Combination: Genomics and Deep Phenotyping for Accelerated Drug Discovery 7 months, 3 weeks ago
Sponsored content brought to you by
Drug discovery and development is such an arduous process; it typically takes more than a decade to achieve a single approval. But researchers can save a lot of time by […]
-
Kathy Vuksanaj wrote a new post, Expanding the CRISPR Toolbox 11 months ago
-
Kathy Vuksanaj wrote a new post, Using Viral Proteins against Bacteria That Cause Acne 11 months, 2 weeks ago
Over 80% of adolescents and an increasing number of adults are affected by acne vulgaris, a skin condition caused by the Cutibacterium acnes bacteria (formerly Propionibacterium acnes). The Institute for […]
-
Kathy Vuksanaj wrote a new post, 3D Bioprinted Organ Just Took Its First "Breath" 1 year, 8 months ago
Rice University researcher’s bioprinting method could be scaled up to one day construct an entire organ and allow organs to be made using some of a patient’s own cells to prevent organ rejection. Researcher’s l […]
-
Kathy Vuksanaj wrote a new post, DNA Day 2019 1 year, 9 months ago
DNA Day, April 25, celebrates the discovery and understanding of DNA and the scientific advances that understanding has made possible. It’s the day where those interested in genomics celebrate the 2003 co […]
-
Kathy Vuksanaj wrote a new post, The First Computer-Generated Bacterial Genome 1 year, 9 months ago
Scientists at ETH Zurich announced they made the first entirely computer-generated bacterial genome covered her in SciShow’s video. The brand new genome, Caulobacter ethensis-2.0, was built by c […]
-
Kathy Vuksanaj wrote a new post, Taking a New Shot at Tumor Vaccines 1 year, 10 months ago
Every tumor is a twisted reflection of the tissue from which it originates, studded with mutated and aberrantly expressed proteins. The immune system has the capacity to recognize these abnormalities, and […]
-
Kathy Vuksanaj wrote a new post, Transient Gene Expression Seeds Plant-Based Bioproduction Systems 1 year, 10 months ago
Recent advances in plant biotechnology have allowed the use of plants and plant cell cultures for the production of pharmaceutical proteins, known as molecular farming. We are now able to exploit the ability of […]
-
-
Kathy Vuksanaj wrote a new post, From Process Development to Scale-up…Facing the Challenges in Vaccine Upstream Bioprocessing 1 year, 12 months ago
In this ebook we share expert views and case studies on some of the hot topics in vaccine bioprocess development. We hope the information on viral vector production, continuous bioprocessing, and process scale-up […]
-
Kathy Vuksanaj wrote a new post, Precision Genomics Takes the High Ground 2 years ago
Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals and 170 clinics that employs close to 2300 physicians and advanced practice clinicians. It serves patients through its insurance […]
- Load More
Home Kathy Vuksanaj
